Outcome | Sample size | In-person | Web-based | Controls | In-person minus controls | p value* | Web-based minus controls | p value* | In-person minus web-based | p value* |
---|---|---|---|---|---|---|---|---|---|---|
Systolic BP (mm Hg) | 568 | -2.2 ± 10.0 | -0.7 ± 10.3 | -2.6 ± 15.4 | 0.4 ± 12.9 | 0.79 | 1.8 ± 13.0 | 0.20 | -1.4 ± 10.1 | 0.17 |
Diastolic BP (mm Hg) | 569 | -1.1 ± 8.6 | -1.6 ± 8.6 | -1.9 ± 11.8 | 0.8 ± 10.3 | 0.56 | 0.3 ± 10.3 | 0.82 | 0.5 ± 8.6 | 0.57 |
Total cholesterol (mmol/L) | 586 | -0.1 ± 0.7 | -0.1 ± 0.6 | -0.2 ± 0.6 | 0.1 ± 0.6 | 0.20 | 0.02 ± 0.7 | 0.86 | 0.1 ± 0.6 | 0.19 |
HDL cholesterol (mmol/L) | 586 | 0.01 ± 0.14 | 0.01 ± 0.16 | -0.01 ± 0.13 | 0.02 ± 0.13 | 0.11 | 0.02 ± 0.14 | 0.18 | 0.003 ± 0.15 | 0.8 |
LDL cholesterol (mmol/L) | 576 | -0.1 ± 0.4 | -0.05 ± 0.4 | -0.09 ± 0.4 | -0.01 ± 0.4 | 0.77 | 0.04 ± 0.4 | 0.34 | -0.05 ± 0.4 | 0.24 |
Triglycerides (mmol/L) | 586 | 1.8 ± 1.0 | 1.8 ± 0.9 | 1.7 ± 0.8 | 0.04 ± 0.55 | 0.50 | 0.05 ± 0.58 | 0.38 | 0.1 ± 0.7 | 0.15 |
A1c (%) | 573 | -0.10 ± 0.40 | -0.16 ± 0.80 | -0.11 ± 0.50 | 0.01 ± 0.45 | 0.79 | -0.05 ± 0.64 | 0.54 | 0.06 ± 0.63 | 0.38 |
EQ-5D VAS score | 647 | 10.3 ± 15.7 | 11.4 ± 17.3 | 11.0 ± 17.8 | 0.7 ± 16.8 | 0.74 | 0.4 ± 17.5 | 0.92 | -1.0 ± 16.6 | 0.52 |
EQ-5D index score | 645 | 0.03 ± 0.05 | 0.02 ± 0.04 | 0.02 ± 0.05 | 0.01 ± 0.05 | 0.11 | 0.001 ± 0.05 | 0.88 | 0.006 | 0.15 |
SF-12 PC score | 639 | 4.1 ± 7.3 | 4.9 ± 6.7 | 3.7 ± 7.2 | 0.3 ± 7.2 | 0.63 | 1.2 ± 6.9 | 0.08 | -0.9 ± 7.0 | 0.21 |
SF-12 MC score | 639 | 4.2 ± 8.1 | 4.1 ± 7.4 | 4.7 ± 8.8 | -0.5 ± 8.5 | 0.67 | -0.6 ± 8.1 | 0.48 | 0.06 ± 7.8 | 0.99 |
WEL score | 649 | 22.3 ± 31.2 | 20.8 ± 29.7 | 22.2 ± 34.6 | 0.1 ± 32.9 | 0.90 | -1.4 ± 32.1 | 0.59 | 1.5 ± 30.4 | 0.58 |
Readiness-to-change score | 650 | -0.08 ± 1.19 | -0.14 ± 1.10 | -0.07 ± 1.30 | 0.003 ± 1.30 | 0.95 | 0.06 ± 1.20 | 0.64 | 0.06 ± 1.13 | 0.54 |
PHQ-8 score | 632 | -2.8 ± 4.4 | -3.1 ± 4.2 | -3.1 ± 4.8 | 0.3 ± 4.6 | 0.63 | 0.04 ± 4.5 | 0.93 | 0.3 ± 4.3 | 0.54 |